HMGN2, a new anti-tumor effector molecule of CD8(+) T cells

BACKGROUND: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells have been implicated as important cells in antitumor responses. Our previous research has shown that high mobility group nucleosomal-binding domain 2 (HMGN2) could be released by IL-2 and PHA stimulated peripheral blood mononucl...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Lin, Hu, Ankang, Luo, Yang, Zhou, Wenjie, Zhang, Ping, Feng, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126642/
https://www.ncbi.nlm.nih.gov/pubmed/25060707
http://dx.doi.org/10.1186/1476-4598-13-178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126642/
https://www.ncbi.nlm.nih.gov/pubmed/25060707
http://dx.doi.org/10.1186/1476-4598-13-178

Ejemplares similares